株式会社Veritas In Silico Logo

株式会社Veritas In Silico

An in silico drug discovery platform creating mRNA-targeting medicines with pharma partners.

130A | T

Overview

Corporate Details

ISIN(s):
N/A
LEI:
Country:
Japan
Address:
品川区西五反田一丁目11番1号
Sector:
Mining and quarrying
Industry:
Mining of non-ferrous metal ores

Description

Veritas In Silico Inc. is a drug discovery platform company specializing in the creation of small molecule and nucleic acid medicines that target messenger RNA (mRNA). The company utilizes its proprietary *in silico* (computational simulation) technologies, combining quantum chemistry calculations with robust high-throughput screening, to design novel therapeutics for previously undruggable targets. Its core business involves establishing joint research and development partnerships with major pharmaceutical companies, earning revenue through milestone payments and future royalties. Veritas In Silico has secured numerous collaborations with leading firms such as Takeda, Shionogi, and Mitsubishi Gas Chemical. The company was listed on the Tokyo Stock Exchange Growth Market in February 2024.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
2025-08-14 08:00
Interim Report
半期報告書-第10期(2025/01/01-2025/12/31)
Japanese 177.7 KB
2025-08-14 08:00
Interim Report
確認書
Japanese 8.8 KB
2025-03-28 05:18
Post-Annual General Meeting Information
臨時報告書
Japanese 27.1 KB
2025-03-28 02:47
Regulatory News Service
内部統制報告書-第9期(2024/01/01-2024/12/31)
Japanese 22.5 KB
2025-03-28 02:47
Regulatory News Service
確認書
Japanese 8.8 KB
2025-03-28 02:46
Annual Report
有価証券報告書-第9期(2024/01/01-2024/12/31)
Japanese 3.1 MB
2024-08-14 08:00
Interim Report
確認書
Japanese 8.7 KB
2024-08-14 08:00
Interim Report
半期報告書-第9期(2024/01/01-2024/12/31)
Japanese 171.1 KB
2024-05-15 09:55
Report Publication Announcement
確認書
Japanese 8.7 KB
2024-05-15 08:00
Quarterly Report
四半期報告書-第9期第1四半期(2024/01/01-2024/03/31)
Japanese 146.8 KB
2024-03-15 07:01
Post-Annual General Meeting Information
臨時報告書
Japanese 23.2 KB
2024-03-15 07:00
Annual Report
有価証券報告書-第8期(2023/01/01-2023/12/31)
Japanese 3.1 MB
2024-02-08 01:05
Regulatory News Service
臨時報告書
Japanese 21.1 KB
2024-01-31 07:00
Registration Form
訂正有価証券届出書(新規公開時)
Japanese 2.4 MB
2024-01-23 07:00
Registration Form
訂正有価証券届出書(新規公開時)
Japanese 2.4 MB

Automate Your Workflow. Get a real-time feed of all 株式会社Veritas In Silico filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

No Financial Data Available

Standardized financial statements for the selected period are not yet available.

Need More History? Access decades of standardized financials for 株式会社Veritas In Silico via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

Company Country Ticker View
Open Up Group Inc. Logo
Provides staffing and outsourcing of engineers for global manufacturing, IT, and construction sectors.
Japan 2154
Optipharm.CO.,LTD Logo
Biotech for animal health and xenotransplantation using genetically engineered pig organs.
South Korea 153710
Organoid-based platforms for drug testing and regenerative therapeutics.
South Korea 476040
Oricon Inc. Logo
Provides entertainment industry data, music charts, web media, and marketing services.
Japan 4800
ORIENTBIO Inc. Logo
Provides animal models & technical services for preclinical R&D to pharma & research institutions.
South Korea 002630
Oryzon Genomics S.A. Logo
Develops epigenetic-based medicines for cancer and central nervous system disorders.
Spain ORY
OSCOTECInc. Logo
A clinical-stage drug discovery company developing innovative medicines for unmet needs.
South Korea 039200
OSE Immunotherapeutics Logo
Develops first-in-class immune therapies for oncology and inflammation, partnering for late-stage.
France OSE
Oxurion NV Logo
Acquires European pharmaceutical subcontractors to build an integrated healthcare services group.
Belgium OXUR
PA Co., Ltd Logo
Offers HR solutions like recruitment media, staffing, and childcare to revitalize local communities.
Japan 4766

Talk to a Data Expert

Have a question? We'll get back to you promptly.